Chemical Compound Review:
Taractan 3-(2-chlorothioxanthen-9- ylidene)-N,N...
Synonyms:
Iaractan, Rentovet, Tactaran, Vetacalm, Traquilan, ...
- Neurolepticlike actions of l-methadone: effect on mescaline-induced altered behavior and on tissue levels of mescaline in mice. Shah, N.S., Hudnall, S.D., May, D., Eargle, D., Yates, J. Biol. Psychiatry (1979)
- Chlorprothixene (taractan) in post-herpetic neuralgia and other severe chronic pains. Nathan, P.W. Pain (1978)
- Polyneuropathy caused by chlorprothixene. Luisto, M. Acta psychiatrica Scandinavica. (1992)
- Contact dermatitis to chlorprothixene. Lepp, U., Schlaak, M., Schulz, K.H. Allergy (1998)
- Acute oliguria associated with chlorprothixene overdosage. Scheithauer, W., Ulrich, W., Kovarik, J., Stummvoll, H.K. Nephron (1988)
- Bromazepam in generalized anxiety. Randomized, multi-practice comparisons with both chlorprothixene and placebo. Kragh-Sørensen, P., Holm, P., Fynboe, C., Schaumburg, E., Andersen, B., Bech, P., Pichard, J. Psychopharmacology (Berl.) (1990)
- Antidepressant combination therapy of endogenous depressions with benzodiazepines or neuroleptics--a study comparing adjuvant treatment with oxazolam versus chlorprothixene. Laux, G., Koenig, W., Pfaff, G. Pharmacopsychiatry (1988)
- Separation of (Z)- and (E)-isomers of thioxanthene and dibenz[b,e]oxepin derivatives with calixarenes and resorcinarenes as additives in nonaqueous capillary electrophoresis. Sokoliess, T., Gronau, M., Menyes, U., Roth, U., Jira, T. Electrophoresis (2003)
- Chlorprothixene-induced systemic lupus erythematosus. McNevin, S., MacKay, M. Journal of clinical psychopharmacology. (1982)
- Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration. Bagli, M., Süverkrüp, R., Quadflieg, R., Höflich, G., Kasper, S., Möller, H.J., Langer, M., Barlage, U., Rao, M.L. J. Pharmacol. Exp. Ther. (1999)
- Efficacy of novel antimicrobials against clinical isolates of opportunistic amebas. Schuster, F.L., Visvesvara, G.S. J. Eukaryot. Microbiol. (1998)
- Trimipramine and other antipsychotics inhibit Campylobacter pylori in vitro. Kristiansen, J.E., Justesen, T., Hvidberg, E.F., Andersen, L.P. Pharmacol. Toxicol. (1989)
- Elimination of F'lac plasmid by different psychotropic drugs and some related compounds. Farkas, S., Molnár, J. Acta microbiologica Academiae Scientiarum Hungaricae. (1979)
- Gamma-hydroxybutyrate versus chlorprothixene/phenobarbital sedation in children undergoing MRI studies. Meyer, S., Gottschling, S., Georg, T., Lothschütz, D., Graf, N., Sitzmann, F.C. Klinische Pädiatrie. (2003)
- Penfluridol, chlorprothixene and haloperidol block fast axonal transport in an order of potency consistent with a mechanism related to inhibition of calmodulin. Lavoie, P.A. Neuropharmacology (1987)
- Tricyclic drugs reduce proton motive force in Leishmania donovani promastigotes. Zilberstein, D., Liveanu, V., Gepstein, A. Biochem. Pharmacol. (1990)
- Mean input times of three oral chlorprothixene formulations assessed by an enhanced least-squares deconvolution method. Bagli, M., Süverkrüp, R., Rao, M.L., Bode, H. Journal of pharmaceutical sciences. (1996)
- On the pharmacokinetics of chlorprothixene in man. Raaflaub, J. Experientia (1975)
- Relation of albinism and drugs to the visual evoked potential of the mouse. Henry, K.R., Rhoades, R.W. Journal of comparative and physiological psychology. (1978)
- Phenolic metabolites of chlorprothixene in man and dog. Breyer-Pfaff, U., Wiest, E., Prox, A., Wachsmuth, H., Protiva, M., Sindelár, K., Friebolin, H., Krauss, D., Kunzelmann, P. Drug Metab. Dispos. (1985)
- Presence of chlorprothixene and its metabolites in breast milk. Matheson, I., Evang, A., Overø, K.F., Syversen, G. Eur. J. Clin. Pharmacol. (1984)
- Chlorprothixene and chlorprothixene-sulfoxide in body fluids from a case of drug overdose. Poklis, A., Maginn, D., Mackell, M.A. Journal of analytical toxicology. (1983)
- The effect of neuroleptics on imipramine demethylation in rat liver microsomes and imipramine and desipramine level in the rat brain. Daniel, W., Melzacka, M. Biochem. Pharmacol. (1986)
- Determination of chlorprothixene and its sulfoxide metabolite in plasma by high-performance liquid chromatography with ultraviolet and amperometric detection. Brooks, M.A., DiDonato, G., Blumenthal, H.P. J. Chromatogr. (1985)
- Simultaneous LC determination of some antidepressants combined with neuroleptics. Karpinska, J., Starczewska, B. Journal of pharmaceutical and biomedical analysis. (2002)
- Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations. Bagli, M., Rao, M.L., Höflich, G., Kasper, S., Langer, M., Barlage, U., Beneke, M., Süverkrüp, R., Möller, H.J. Arzneimittel-Forschung. (1996)
- Hemoperfusion in severe chlorprothixene overdose. Köppel, C., Schirop, T., Ibe, K., Tenczer, J., Ehrenburg, J., Gayer, J. Intensive care medicine. (1987)
- ELISA screening with GC-MS confirmation of the tranquilizer chlorprothixene administered in subtherapeutic doses to horses. Delbeke, F.T., Teale, P., Debackere, M., Houghton, E. Journal of pharmaceutical and biomedical analysis. (1993)
- A controlled comparative study of chlorprothixene vs. haloperidol in chronic schizophrenia. Fux, M., Belmaker, R.H. The Israel journal of psychiatry and related sciences. (1991)